[{"Assets_0_Q2_USD":3989725000.0,"CommonStockSharesOutstanding_0_Q2_shares":166590504.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":974000.0,"NetIncomeLoss_1_Q2_USD":-32836000.0,"NetIncomeLoss_2_Q2_USD":-190164000.0,"StockholdersEquity_0_Q2_USD":860150000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":302835000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":526716000.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON PHARMA PLC","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]